{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T02:43:20Z","timestamp":1783651400992,"version":"3.55.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,2,7]],"date-time":"2023-02-07T00:00:00Z","timestamp":1675728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,7]],"date-time":"2023-02-07T00:00:00Z","timestamp":1675728000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100007700","name":"Miami Center for AIDS Research","doi-asserted-by":"publisher","award":["P30AI1073961"],"award-info":[{"award-number":["P30AI1073961"]}],"id":[{"id":"10.13039\/100007700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Addict Sci Clin Pract"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Hospitalizations for severe injection drug use-related infections (SIRIs) are characterized by high costs, frequent patient-directed discharge, and high readmission rates. Beyond the health system impacts, these admissions can be traumatizing to people who inject drugs (PWID), who often receive inadequate treatment for their substance use disorders (SUD). The Jackson SIRI team was developed as an integrated infectious disease\/SUD treatment intervention for patients hospitalized at a public safety-net hospital in Miami, Florida in 2020. We conducted a qualitative study to identify patient- and clinician-level perceived implementation barriers and facilitators to the SIRI team intervention.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Participants were patients with history of SIRIs (n\u2009=\u20097) and healthcare clinicians (n\u2009=\u20098) at one implementing hospital (Jackson Memorial Hospital). Semi-structured qualitative interviews were performed with a guide created using the Consolidated Framework for Implementation Research (CFIR). Interviews were transcribed, double coded, and categorized by study team members using CFIR constructs.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Implementation barriers to the SIRI team intervention identified by participants included: (1) complexity of the\u00a0SIRI team intervention; (2) lack of resources for PWID experiencing homelessness, financial insecurity, and uninsured status; (3) clinician-level stigma and lack of knowledge around addiction and medications for opioid use disorder (OUD); and (4) concerns about underinvestment in the intervention. Implementation facilitators of the intervention included: (1) a non-judgmental, harm reduction-oriented approach; (2) the team\u2019s advocacy for PWID as a means of institutional culture change; (3) provision of close post-hospital follow-up that is often inaccessible\u00a0for PWID; (4) strong communication with patients and their hospital physicians; and (5) addressing diverse needs such as housing, insurance, and psychological wellbeing.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Integration of infectious disease and SUD treatment is a promising approach to managing patients with SIRIs. Implementation success depends on institutional buy-in, holistic care beyond the medical domain, and an ethos rooted in harm reduction across multilevel (inner and outer) implementation contexts.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13722-023-00363-4","type":"journal-article","created":{"date-parts":[[2023,2,7]],"date-time":"2023-02-07T03:03:30Z","timestamp":1675739010000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Implementation of an integrated infectious disease and substance use disorder team for injection drug use-associated infections: a qualitative study"],"prefix":"10.1186","volume":"18","author":[{"given":"Bel\u00e9n","family":"Hervera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace","family":"Seo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tyler S.","family":"Bartholomew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa A.","family":"Chueng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Suarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David W.","family":"Forrest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salma","family":"Hernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan E.","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hansel E.","family":"Tookes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Doblecki-Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8505-6617","authenticated-orcid":false,"given":"David P.","family":"Serota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,7]]},"reference":[{"key":"363_CR1","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.drugalcdep.2016.11.029","volume":"171","author":"AP Sarah Larney","year":"2017","unstructured":"Sarah Larney AP, Mathers BM, Hickman M, Degenhardt L. A systematic review of injecting-related injury and disease among people who inject drugs. Drug Alcohol Depend. 2017;171:39\u201349.","journal-title":"Drug Alcohol Depend"},{"issue":"5","key":"363_CR2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0196944","volume":"13","author":"D Dahlman","year":"2018","unstructured":"Dahlman D, Berge J, Bjorkman P, Nilsson AC, Hakansson A. Both localized and systemic bacterial infections are predicted by injection drug use: a prospective follow-up study in Swedish criminal justice clients. PLoS ONE. 2018;13(5): e0196944.","journal-title":"PLoS ONE"},{"issue":"1","key":"363_CR3","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s12954-021-00492-6","volume":"18","author":"P Tsybina","year":"2021","unstructured":"Tsybina P, Kassir S, Clark M, Skinner S. Hospital admissions and mortality due to complications of injection drug use in two hospitals in Regina, Canada: retrospective chart review. Harm Reduct J. 2021;18(1):44.","journal-title":"Harm Reduct J"},{"issue":"3","key":"363_CR4","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1093\/cid\/ciaa823","volume":"72","author":"AE Coye","year":"2021","unstructured":"Coye AE, Bornstein KJ, Bartholomew TS, Li H, Wong S, Janjua NZ, et al. Hospital costs of injection drug use in Florida. Clin Infect Dis. 2021;72(3):499\u2013502.","journal-title":"Clin Infect Dis"},{"issue":"22","key":"363_CR5","doi-asserted-by":"publisher","first-page":"569","DOI":"10.15585\/mmwr.mm6622a1","volume":"66","author":"AT Fleischauer","year":"2017","unstructured":"Fleischauer AT, Ruhl L, Rhea S, Barnes E. Hospitalizations for endocarditis and associated health care costs among persons with diagnosed drug dependence - North Carolina, 2010\u20132015. MMWR Morb Mortal Wkly Rep. 2017;66(22):569\u201373.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"4","key":"363_CR6","doi-asserted-by":"publisher","first-page":"E93","DOI":"10.1503\/cmaj.180694","volume":"191","author":"MA Weir","year":"2019","unstructured":"Weir MA, Slater J, Jandoc R, Koivu S, Garg AX, Silverman M. The risk of infective endocarditis among people who inject drugs: a retrospective, population-based time series analysis. CMAJ. 2019;191(4):E93\u20139.","journal-title":"CMAJ"},{"issue":"5","key":"363_CR7","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1016\/j.mayocp.2019.08.023","volume":"95","author":"M Alkhouli","year":"2020","unstructured":"Alkhouli M, Alqahtani F, Alhajji M, Berzingi CO, Sohail MR. Clinical and economic burden of hospitalizations for infective endocarditis in the United States. Mayo Clin Proc. 2020;95(5):858\u201366.","journal-title":"Mayo Clin Proc"},{"issue":"6","key":"363_CR8","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.012465","volume":"9","author":"M Mori","year":"2020","unstructured":"Mori M, Brown KJ, Bin Mahmood SU, Geirsson A, Mangi AA. Trends in infective endocarditis hospitalizations, characteristics, and valve operations in patients with opioid use disorders in the United States: 2005\u20132014. J Am Heart Assoc. 2020;9(6): e012465.","journal-title":"J Am Heart Assoc"},{"issue":"5","key":"363_CR9","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1377\/hlthaff.2015.1424","volume":"35","author":"MV Ronan","year":"2016","unstructured":"Ronan MV, Herzig SJ. Hospitalizations related to opioid abuse\/dependence and associated serious infections increased sharply, 2002\u201312. Health Aff (Millwood). 2016;35(5):832\u20137.","journal-title":"Health Aff (Millwood)"},{"key":"363_CR10","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.jsat.2019.04.008","volume":"102","author":"B Bearnot","year":"2019","unstructured":"Bearnot B, Mitton JA, Hayden M, Park ER. Experiences of care among individuals with opioid use disorder-associated endocarditis and their healthcare providers: results from a qualitative study. J Subst Abuse Treat. 2019;102:16\u201322.","journal-title":"J Subst Abuse Treat"},{"key":"363_CR11","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.drugalcdep.2019.01.037","volume":"198","author":"DL Biancarelli","year":"2019","unstructured":"Biancarelli DL, Biello KB, Childs E, Drainoni M, Salhaney P, Edeza A, et al. Strategies used by people who inject drugs to avoid stigma in healthcare settings. Drug Alcohol Depend. 2019;198:80\u20136.","journal-title":"Drug Alcohol Depend"},{"key":"363_CR12","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.drugpo.2018.09.001","volume":"65","author":"K Dunleavy","year":"2019","unstructured":"Dunleavy K, Hope V, Roy K, Taylor A. The experiences of people who inject drugs of skin and soft tissue infections and harm reduction: a qualitative study. Int J Drug Policy. 2019;65:65\u201372.","journal-title":"Int J Drug Policy"},{"issue":"7","key":"363_CR13","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1093\/cid\/ciy632","volume":"68","author":"AC Miller","year":"2019","unstructured":"Miller AC, Polgreen PM. Many opportunities to record, diagnose, or treat injection drug-related infections are missed: a population-based cohort study of inpatient and emergency department settings. Clin Infect Dis. 2019;68(7):1166\u201375.","journal-title":"Clin Infect Dis"},{"issue":"7","key":"363_CR14","doi-asserted-by":"publisher","first-page":"ofz289-ofz","DOI":"10.1093\/ofid\/ofz289","volume":"6","author":"DP Serota","year":"2019","unstructured":"Serota DP, Niehaus ED, Schechter MC, Jacob JT, Jones J, Ray SM, et al. Disparity in quality of infectious disease vs addiction care among patients with injection drug use-associated staphylococcus aureus bacteremia. Open Forum Infect Dis. 2019;6(7):ofz289-ofz.","journal-title":"Open Forum Infect Dis."},{"issue":"3","key":"363_CR15","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1111\/jocs.16201","volume":"37","author":"B Muncan","year":"2022","unstructured":"Muncan B, Kim EK, Amabile A, Weimer MB, Nguemeni Tiako MJ, Vallabhajosyula P, et al. Cardiac surgeons\u2019 perspectives and practices regarding people who use drugs: a scoping review. J Card Surg. 2022;37(3):630\u20139.","journal-title":"J Card Surg"},{"issue":"5(Supplement_5)","key":"363_CR16","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1093\/infdis\/jiaa055","volume":"222","author":"GE Cooksey","year":"2020","unstructured":"Cooksey GE, Epps JL, Moye RA, Patel N, Shorman MA, Veve MP. Impact of a plan of care protocol on patient outcomes in people who inject drugs with infective endocarditis. J Infect Dis. 2020;222(5(Supplement_5)):506-S12.","journal-title":"J Infect Dis"},{"key":"363_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2021.108465","volume":"126","author":"A Hazen","year":"2021","unstructured":"Hazen A, Pizzicato L, Hom J, Johnson C, Viner KM. Association between discharges against medical advice and readmission in patients treated for drug injection-related skin and soft tissue infections. J Subst Abuse Treat. 2021;126: 108465.","journal-title":"J Subst Abuse Treat"},{"issue":"1","key":"363_CR18","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s13011-021-00383-w","volume":"16","author":"AE Coye","year":"2021","unstructured":"Coye AE, Jones MT, Bornstein KJ, Tookes HE, St Onge JE. A missed opportunity: underutilization of inpatient behavioral health services to reduce injection drug use sequelae in Florida. Subst Abuse Treat Prev Policy. 2021;16(1):46.","journal-title":"Subst Abuse Treat Prev Policy"},{"key":"363_CR19","volume-title":"Opportunities to improve opioid use disorder and infectious disease services integrating responses to a dual epidemic","author":"National Academies of Sciences E","year":"2020","unstructured":"National Academies of Sciences E, Medicine, Health, Medicine D, Board on Population H, Public Health P, et al. Opportunities to improve opioid use disorder and infectious disease services integrating responses to a dual epidemic. Washington DC: National Academies Press; 2020."},{"issue":"5","key":"363_CR20","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1093\/cid\/ciz804","volume":"70","author":"DP Serota","year":"2020","unstructured":"Serota DP, Barocas JA, Springer SA. Infectious complications of addiction: a call for a new subspecialty within infectious diseases. Clin Infect Dis. 2020;70(5):968\u201372.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"363_CR21","doi-asserted-by":"publisher","first-page":"ofab633","DOI":"10.1093\/ofid\/ofab633","volume":"9","author":"S Lewis","year":"2022","unstructured":"Lewis S, Liang SY, Schwarz ES, Liss DB, Winograd RP, Nolan NS, et al. Patients with serious injection drug use-related infections who experience patient-directed discharges on oral antibiotics have high rates of antibiotic adherence but require multidisciplinary outpatient support for retention in care. Open Forum Infect Dis. 2022;9(2):ofab633.","journal-title":"Open Forum Infect Dis"},{"key":"363_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ypmed.2019.105760","volume":"128","author":"LC Fanucchi","year":"2019","unstructured":"Fanucchi LC, Walsh SL, Thornton AC, Lofwall MR. Integrated outpatient treatment of opioid use disorder and injection-related infections: a description of a new care model. Prev Med. 2019;128: 105760.","journal-title":"Prev Med"},{"key":"363_CR23","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000000916","author":"MB Weimer","year":"2021","unstructured":"Weimer MB, Falker CG, Seval N, Golden M, Hull SC, Geirsson A, et al. The need for multidisciplinary hospital teams for injection drug use-related infective endocarditis. J Addict Med. 2021. https:\/\/doi.org\/10.1097\/ADM.0000000000000916.","journal-title":"J Addict Med"},{"key":"363_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtcvs.2021.10.048","author":"ML Paras","year":"2021","unstructured":"Paras ML, Wolfe SB, Bearnot B, Sundt TM, Marinacci L, Dudzinski DM, et al. Multidisciplinary team approach to confront the challenge of drug use-associated infective endocarditis. J Thorac Cardiovasc Surg. 2021. https:\/\/doi.org\/10.1016\/j.jtcvs.2021.10.048.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"363_CR25","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-022-07618-x","author":"H Englander","year":"2022","unstructured":"Englander H, Jones A, Krawczyk N, Patten A, Roberts T, Korthuis PT, et al. A taxonomy of hospital-based addiction care models: a scoping review and key informant interviews. J Gen Intern Med. 2022. https:\/\/doi.org\/10.1007\/s11606-022-07618-x.","journal-title":"J Gen Intern Med."},{"issue":"11","key":"363_CR26","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1093\/cid\/ciy924","volume":"68","author":"LR Marks","year":"2019","unstructured":"Marks LR, Munigala S, Warren DK, Liang SY, Schwarz ES, Durkin MJ. Addiction medicine consultations reduce readmission rates for patients with serious infections from opioid use disorder. Clin Infect Dis\u202f: an official publication of the Infectious Diseases Society of America. 2019;68(11):1935\u20137.","journal-title":"Clin Infect Dis : an official publication of the Infectious Diseases Society of America"},{"issue":"2","key":"363_CR27","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1097\/ADM.0000000000000725","volume":"15","author":"NS Nolan","year":"2021","unstructured":"Nolan NS, Marks LR, Liang SY, Durkin MJ. Medications for opioid use disorder associated with less against medical advice discharge among persons who inject drugs hospitalized with an invasive infection. J Addict Med. 2021;15(2):155\u20138.","journal-title":"J Addict Med"},{"issue":"3","key":"363_CR28","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1093\/cid\/ciaa062","volume":"72","author":"JA Barocas","year":"2021","unstructured":"Barocas JA, Morgan JR, Wang J, McLoone D, Wurcel A, Stein MD. Outcomes associated with medications for opioid use disorder among persons hospitalized for infective endocarditis. Clin Infect Dis. 2021;72(3):472\u20138.","journal-title":"Clin Infect Dis"},{"key":"363_CR29","doi-asserted-by":"publisher","DOI":"10.1111\/add.15393","author":"Y Jo","year":"2021","unstructured":"Jo Y, Nosal R, Vittori A, Cordova L, Vandever C, Alvarez C, et al. Effect of initiation of medications for opioid use disorder on hospitalization outcomes for endocarditis and osteomyelitis in a large private hospital system in the United States, 2014-2018. Addiction. 2021. https:\/\/doi.org\/10.1111\/add.15393.","journal-title":"Addiction"},{"issue":"12","key":"363_CR30","doi-asserted-by":"publisher","first-page":"2796","DOI":"10.1007\/s11606-019-05251-9","volume":"34","author":"H Englander","year":"2019","unstructured":"Englander H, Dobbertin K, Lind BK, Nicolaidis C, Graven P, Dorfman C, et al. Inpatient addiction medicine consultation and post-hospital substance use disorder treatment engagement: a propensity-matched analysis. J Gen Intern Med. 2019;34(12):2796\u2013803.","journal-title":"J Gen Intern Med"},{"issue":"8","key":"363_CR31","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1007\/s11606-017-4077-z","volume":"32","author":"SE Wakeman","year":"2017","unstructured":"Wakeman SE, Metlay JP, Chang Y, Herman GE, Rigotti NA. Inpatient addiction consultation for hospitalized patients increases post-discharge abstinence and reduces addiction severity. J Gen Intern Med. 2017;32(8):909\u201316.","journal-title":"J Gen Intern Med"},{"issue":"1","key":"363_CR32","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1080\/07853890.2021.1993326","volume":"53","author":"DP Serota","year":"2021","unstructured":"Serota DP, Tookes HE, Hervera B, Gayle BM, Roeck CR, Suarez E, et al. Harm reduction for the treatment of patients with severe injection-related infections: description of the Jackson SIRI Team. Ann Med. 2021;53(1):1960\u20138.","journal-title":"Ann Med"},{"key":"363_CR33","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/1748-5908-4-50","volume":"4","author":"LJ Damschroder","year":"2009","unstructured":"Damschroder LJ, Aron DC, Keith RE, Kirsh SR, Alexander JA, Lowery JC. Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science. Implement Sci. 2009;4:50.","journal-title":"Implement Sci"},{"key":"363_CR34","volume-title":"Qualitative data analysis: an expanded sourcebook","author":"MBHA Miles","year":"1994","unstructured":"Miles MBHA. Qualitative data analysis: an expanded sourcebook. Thousand Oaks: Sage; 1994."},{"issue":"2","key":"363_CR35","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1177\/1098214005283748","volume":"27","author":"DR Thomas","year":"2006","unstructured":"Thomas DR. A general inductive approach for analyzing qualitative evaluation data. Am J Eval. 2006;27(2):237\u201346.","journal-title":"Am J Eval"},{"key":"363_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2021.103112","volume":"93","author":"BE Meyerson","year":"2021","unstructured":"Meyerson BE, Russell DM, Kichler M, Atkin T, Fox G, Coles HB. I don\u2019t even want to go to the doctor when I get sick now: healthcare experiences and discrimination reported by people who use drugs, Arizona 2019. Int J Drug Policy. 2021;93: 103112.","journal-title":"Int J Drug Policy"},{"key":"363_CR37","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.drugalcdep.2018.06.010","volume":"190","author":"PJ Summers","year":"2018","unstructured":"Summers PJ, Hellman JL, MacLean MR, Rees VW, Wilkes MS. Negative experiences of pain and withdrawal create barriers to abscess care for people who inject heroin. A mixed methods analysis. Drug Alcohol Depend. 2018;190:200\u20138.","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"363_CR38","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s12954-019-0345-z","volume":"16","author":"AR Gilbert","year":"2019","unstructured":"Gilbert AR, Hellman JL, Wilkes MS, Rees VW, Summers PJ. Self-care habits among people who inject drugs with skin and soft tissue infections: a qualitative analysis. Harm Reduct J. 2019;16(1):69.","journal-title":"Harm Reduct J"},{"issue":"4","key":"363_CR39","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1111\/add.13214","volume":"111","author":"R McNeil","year":"2016","unstructured":"McNeil R, Kerr T, Pauly B, Wood E, Small W. Advancing patient-centered care for structurally vulnerable drug-using populations: a qualitative study of the perspectives of people who use drugs regarding the potential integration of harm reduction interventions into hospitals. Addiction. 2016;111(4):685\u201394.","journal-title":"Addiction"},{"key":"363_CR40","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.jsat.2018.06.011","volume":"92","author":"LC Fanucchi","year":"2018","unstructured":"Fanucchi LC, Lofwall MR, Nuzzo PA, Walsh SL. In-hospital illicit drug use, substance use disorders, and acceptance of residential treatment in a prospective pilot needs assessment of hospitalized adults with severe infections from injecting drugs. J Subst Abuse Treat. 2018;92:64\u20139.","journal-title":"J Subst Abuse Treat"},{"issue":"1","key":"363_CR41","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1097\/ADM.0000000000000819","volume":"16","author":"C King","year":"2022","unstructured":"King C, Collins D, Patten A, Nicolaidis C, Englander H. Trust in hospital physicians among patients with substance use disorder referred to an addiction consult service: a mixed-methods study. J Addict Med. 2022;16(1):41\u20138.","journal-title":"J Addict Med"},{"issue":"1","key":"363_CR42","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1186\/s12879-021-06514-9","volume":"21","author":"MK Sikka","year":"2021","unstructured":"Sikka MK, Gore S, Vega T, Strnad L, Gregg J, Englander H. \u201cOPTIONS-DC\u201d, a feasible discharge planning conference to expand infection treatment options for people with substance use disorder. BMC Infect Dis. 2021;21(1):772.","journal-title":"BMC Infect Dis"},{"key":"363_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.cct.2021.106394","volume":"105","author":"N Seval","year":"2021","unstructured":"Seval N, Frank CA, Litwin AH, Roth P, Schade MA, Pavlicova M, et al. Design and methods of a multi-site randomized controlled trial of an integrated care model of long-acting injectable buprenorphine with infectious disease treatment among persons hospitalized with infections and opioid use disorder. Contemp Clin Trials. 2021;105: 106394.","journal-title":"Contemp Clin Trials"},{"issue":"2","key":"363_CR44","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1001\/jama.2016.8914","volume":"316","author":"LR Metsch","year":"2016","unstructured":"Metsch LR, Feaster DJ, Gooden L, Matheson T, Stitzer M, Das M, et al. Effect of patient navigation with or without financial incentives on viral suppression among hospitalized patients with HIV infection and substance use: a randomized clinical trial. JAMA. 2016;316(2):156\u201370.","journal-title":"JAMA"},{"issue":"4","key":"363_CR45","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1080\/08897077.2020.1809608","volume":"42","author":"SE Wakeman","year":"2021","unstructured":"Wakeman SE, Rigotti NA, Herman GE, Regan S, Chang Y, Snow R, et al. The effectiveness of post-discharge navigation added to an inpatient addiction consultation for patients with substance use disorder; a randomized controlled trial. Subst Abus. 2021;42(4):646\u201353.","journal-title":"Subst Abus"},{"issue":"7","key":"363_CR46","doi-asserted-by":"publisher","first-page":"899","DOI":"10.7326\/M20-5475","volume":"174","author":"J Gryczynski","year":"2021","unstructured":"Gryczynski J, Nordeck CD, Welsh C, Mitchell SG, O\u2019Grady KE, Schwartz RP. Preventing hospital readmission for patients with comorbid substance use disorder\u202f: a randomized trial. Ann Intern Med. 2021;174(7):899\u2013909.","journal-title":"Ann Intern Med"},{"key":"363_CR47","unstructured":"Integrated Care and Treatment for Severe Infectious Diseases and Substance Use Disorders (SUD) among Hospitalized Patients. 2022. https:\/\/nida.nih.gov\/about-nida\/organization\/cctn\/ctn\/research-studies\/integrated-care-treatment-severe-infectious-diseases-substance-use-disorders-sud-among-hospitalized."}],"container-title":["Addiction Science &amp; Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13722-023-00363-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13722-023-00363-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13722-023-00363-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T13:29:18Z","timestamp":1720704558000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascpjournal.biomedcentral.com\/articles\/10.1186\/s13722-023-00363-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,7]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["363"],"URL":"https:\/\/doi.org\/10.1186\/s13722-023-00363-4","relation":{},"ISSN":["1940-0640"],"issn-type":[{"value":"1940-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,7]]},"assertion":[{"value":"6 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the institutional review board of the University of Miami and the clinical trials office of Jackson Memorial Hospital. Participants completed a verbal informed consent process.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors consent to the publication of this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflict of interest and no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8"}}